BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  INSIGHTEC Gets a $150M Boost From Koch Disruptive Technologies

  The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications.

  December 14, 2017

   · 

  4 min read
• Business

  KalVista Pharmaceuticals Reports Fiscal Second Quarter Results

  Revenue was $1.1 million for the three months ended October 31, 2017, compared to $0.2 million for the same period in 2016.

  December 14, 2017

   · 

  8 min read
• Biotech Beach

  Tocagen Added to NASDAQ Biotechnology Index

  Tocagen today announced it has been selected for addition to the NASDAQ Biotechnology Index, which will become effective prior to the open of U.S. markets on Monday, December 18, 2017.

  December 14, 2017

   · 

  1 min read
• Business

  General Automation Lab Technologies Partners With Lawrence Livermore National Laboratory to Improve Biofuel Production

  Lawrence Livermore National Laboratory has been awarded a 3 year $1.5M grant by the U.S. Department of Energy to improve the growth and efficiency of biofuel-producing algae through the alteration of their microbiomes.

  December 14, 2017

   · 

  3 min read
• Biotech Beach

  Ambry Names Tom Schoenherr as Chief Commercial Officer

  Tom’s primary role will be to build upon Ambry’s success in the genetic testing space following the successful acquisition by Konica Minolta.

  December 14, 2017

   · 

  3 min read
• Business

  Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors

  Protagonist Therapeutics today announced the appointment of Sarah Noonberg, M.D., Ph.D., CMO of Prothena, to the Protagonist Board of Directors.

  December 14, 2017

   · 

  5 min read
• Genetown

  Corindus Announces First Commercial Installation of CorPath GRX System Outside of U.S.

  Corindus will partner with Apex Heart Institute to develop a Global Center of Excellence to train interventional cardiologists on robotic-assisted percutaneous coronary interventions (PCI).

  December 14, 2017

   · 

  5 min read
• Drug Development

  Trovagene Submits Protocol to FDA for Phase II Clinical Trial of PCM-075 in Combination With Zytiga for Metastatic Castration-Resistant Prostate Cancer

  In this multi-center, open-label, Phase 2 trial, PCM-075 in combination with the standard dose of abiraterone and prednisone, all administered orally, will be evaluated for safety and efficacy.

  December 14, 2017

   · 

  8 min read
• FDA

  Medimetriks Pharma Receives FDA Approval for Xepi (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

  The approval of Xepi is based on a clinical development program that includes the results of two phase 3 trials.

  December 14, 2017

   · 

  5 min read
• Pharm Country

  Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results Conference Call on December 21, 2017

  The conference call and live audio webcast will begin at 10:00 a.m. Eastern time on Thursday, December 21, 2017.

  December 14, 2017

   · 

  3 min read